home / stock / lly / lly articles

LLY Articles, Eli Lilly and Company - From 04/30/24

Stock Information
Company Name: Eli Lilly and Company
Stock Symbol: LLY
Market: NYSE
Website: lilly.com
Menu
LLY LLY Quote LLY Short LLY News LLY Articles LLY Message Board
Get LLY Alerts

News, Short Squeeze, Breakout and More Instantly...
Eli Lilly's Weight-Loss Drug Still Going Strong, Boosts Annual Forecast | Benzinga

Tuesday, Eli Lilly And Co (NYSE:LLY) reported first-quarter revenue of $8.77 billion, up 26% year over year, marginally missing the ...
How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q1 Earnings Report | Benzinga

Eli Lilly and Company (NYSE:LLY) is set to report first-quarter earnings on Tuesday, April 30. Analysts expect the Indianapolis, Indiana-based comp...

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week | Benzinga

Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. As we look ahead to the unfolding week, it r...

Jim Cramer Weighs In Ahead Of Apple, Amazon, Eli Lilly Earnings: 'We Have To Run Such A Ridiculous Gauntlet Next Week' | Benzinga

Jim Cramer, the host of CNBC’s “Mad Money,” has outlined the key events that investors should keep an eye on in the upcoming week...
What Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo Nordisk | Benzinga

The Senate Committee on Health, Education, Labor, and Pensions is reportedly scrutinizing  Novo Nordisk A/S (NYSE:NVO) ‘s pric...

Eli Lilly Aims To Close Supply-Demand Gap For Zepbound/Mounjaro As It Acquires Manufacturing Facility From Nexus Pharma | Benzinga

On Monday, Eli Lilly and Company (NYSE:LLY) agreed to acquire a manufacturing facility from Nexus Pharmaceuticals. Th...

Changing Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food Spending | Benzinga

A recent survey conducted by Morgan Stanley reveals that the use of GLP-1 drugs, popular for weight loss and diabetes, is affecting consu...
Exploring The Competitive Space: Eli Lilly and Co Versus Industry Peers In Pharmaceuticals | Benzinga

Amidst today's fast-paced and highly competitive business environment, it is crucial for investors and industry enthusiasts to conduct compreh...

Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025 | Benzinga

The GLP-1 class of drugs for weight loss has gained tremendous popularity but is struggling with a shortage that could extend into 2025. Who says t...

Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 15 Years | Benzinga

Eli Lilly and Co (NYSE:LLY) has outperformed the market over the past 15 years by 10.71% on an annualized basis producing an average annual return ...
Previous 10 Next 10